BridgeBio Pharma Inc (NASDAQ:BBIO)
| 26.34 Delayed Data As of Sep 29 |  -0.79 / -2.91%Today’s Change | 6.64 Today|||52-Week Range 36.36 | +245.67% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2017 | 2018 | -- | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | -- | -- | -- |
| Depreciation And Amortization | 260.0K | 245.0K | -- | -- | ||
| Operating Expenses | Gross Income | -260.0K | -245.0K | -- | -- | |
| General Expenses | 43.6M | 183.4M | -- | -- | ||
| Research And Development | 30.6M | 140.1M | -- | -- | ||
| Total Operating Expenses | 43.9M | 183.7M | -- | -- | ||
| Non-Operating Expenses | Operating Income | -43.9M | -183.7M | -- | -- | |
| Extraordinary Credit | 0.00 | 19.1M | -- | -- | ||
| Interest Expense On Debt | 13.0K | 2.5M | -- | -- | ||
| Other Expenses | 0.00 | -4.3M | -- | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -43.8M | -169.5M | -- | -- | |
| Minority Interest | -13.3M | -38.7M | -- | -- | ||
| Preferred Dividend | -5.7M | -13.3M | -- | -- | ||
| Net Income | -30.6M | -130.7M | -- | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 117.2M | 123.0M | -- | -- | |
| Shares To Calculate EPS Diluted | 117.2M | 123.0M | -- | -- | ||
| Earnings Per Share | EPS | -$0.31 | -$1.17 | -- | -- | |
| EPS Diluted | -$0.31 | -$1.17 | -- | -- | ||
